These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 467643)

  • 1. Purification of human complement subcomponent C4. C4 cleavage by C1s.
    Reboul A; Thielens N; Villiers MB; Colomb MG
    FEBS Lett; 1979 Jul; 103(1):156-61. PubMed ID: 467643
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of C1s and C4. A binding phenomenon.
    Taubman SB
    Biochim Biophys Acta; 1975 Jun; 393(2):542-55. PubMed ID: 125105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1.
    Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG
    FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646
    [No Abstract]   [Full Text] [Related]  

  • 4. The identification of a previously unrecognized subcomponent of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):482-7. PubMed ID: 807639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage products of C4b produced by enzymes in human serum.
    Shiraishi S; Stroud RM
    Immunochemistry; 1975 Dec; 12(12):935-9. PubMed ID: 815169
    [No Abstract]   [Full Text] [Related]  

  • 6. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the enzymatic properties of human complement subcomponent C1s by treatment with human plasma kallikrein.
    Okada F; Takahashi K; Nagasawa S; Koyama J
    J Biochem; 1987 Oct; 102(4):939-46. PubMed ID: 3325504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first component of complement as a constituent of human salivary sediment.
    Wirtz GH; Price RA; Mutchler BA; Miller RW
    Arch Oral Biol; 1987; 32(7):505-8. PubMed ID: 3479089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain.
    Matsumoto M; Nagaki K; Kitamura H; Kuramitsu S; Nagasawa S; Seya T
    J Immunol; 1989 Apr; 142(8):2743-50. PubMed ID: 2522968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides.
    Nagaki K; Inai S
    Int Arch Allergy Appl Immunol; 1976; 50(2):172-80. PubMed ID: 128530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic cleavage of an activated subcomponent of the first component of rabbit complement, C1s.
    Mori Y; Ueda E; Takeuchi T; Taniuchi S; Koyama J
    J Biochem; 1980 Jun; 87(6):1757-63. PubMed ID: 6447146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purification and characterization of bovine C4, the fourth component of complement.
    Booth NA; Campbell RD; Fothergill JE
    Biochem J; 1979 Mar; 177(3):959-65. PubMed ID: 312644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: C1-esterase inactivators and C4 in malignant diseases.
    Bach-Martensen N; Osther K; Stroyer I
    Lancet; 1975 Sep; 2(7933):499-500. PubMed ID: 51308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in the methods of isolation and purification of complement components].
    Takahashi K; Nagasawa S
    Nihon Rinsho; 1979 May; 37(5):937-42. PubMed ID: 381724
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation of two forms of activated C1s, a subcomponent of the first component of rabbit complement.
    Ishizaki E; Yoshioka Y; Mori Y; Koyama J
    J Biochem; 1976 Dec; 80(6):1423-7. PubMed ID: 1035218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
    Doekes G; Vanes LA; Daha MR
    Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of C4 on C1 binding and activation.
    Malmheden Yman I; Stålenheim G; Sjöquist J
    Scand J Immunol; 1982 Jun; 15(6):587-93. PubMed ID: 6214843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex.
    Bartholomew RM; Esser AF
    J Immunol; 1977 Dec; 119(6):1916-22. PubMed ID: 915287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.